» Articles » PMID: 23889858

Associations of Retrospective and Concurrent Lipid Levels with Subclinical Atherosclerosis Prediction After 20 Years of Follow-up: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

Overview
Journal Ann Epidemiol
Publisher Elsevier
Specialty Public Health
Date 2013 Jul 30
PMID 23889858
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Using data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, we sought to determine how well lipids measured at baseline and at 20 years predict the presence of subclinical atherosclerosis.

Methods: Complete risk factor, coronary artery calcification (CAC), and carotid intima media thickness (CIMT) data were available for 2435 participants. Lipids were categorized into quartiles, CAC at Y20 was dichotomized as present/absent, and CIMT was dichotomized as ≥84 or <84th overall percentile. Multivariable logistic regression was used to model the association between lipids and CAC/CIMT. C statistics were used to assess the discriminative value of each lipid measure in predicting the presence of CAC or CIMT at Y20.

Results: Lipid levels measured in young adulthood as well as middle age were both associated with subclinical disease in middle age. The discriminatory value of lipids was virtually identical at baseline, when participants were 18-30 years of age, and 20 years later. Neither baseline nor Y20 lipid data were strong predictors of Y20 subclinical disease despite statistically significant associations.

Conclusions: These results are consistent with a growing body of evidence that early-life exposure to nonoptimal lipids matters and lifestyle modifications administered earlier in the lifespan could slow the progress of the atherosclerotic plaques.

Citing Articles

Male Gender Expressivity and Diagnosis and Treatment of Cardiovascular Disease Risks in Men.

Glasser N, Jameson J, Huang E, Kronish I, Lindau S, Peek M JAMA Netw Open. 2024; 7(10):e2441281.

PMID: 39453653 PMC: 11512345. DOI: 10.1001/jamanetworkopen.2024.41281.


The Development and Pilot Testing of an Evidence-Based Cardiovascular Disease Risk-Prevention Program to Promote Healthy Lifestyle Behaviors Among African-American College Students - .

Duren-Winfield V, Blackman Carr L, McCauley G, Onsomu E, Roberson K, Williams J J Best Pract Health Prof Divers. 2022; 14(1):44-62.

PMID: 35310081 PMC: 8929670.


Metabolite Profiling of Osteoporosis and Atherosclerosis in Postmenopausal Women: A Cross-Sectional Study.

Varri M, Niskanen L, Tuomainen T, Honkanen R, Kroger H, Tuppurainen M Vasc Health Risk Manag. 2020; 16:515-524.

PMID: 33293818 PMC: 7719314. DOI: 10.2147/VHRM.S279028.


Awareness of Cardiovascular Risk Factors in U.S. Young Adults Aged 18-39 Years.

Bucholz E, Gooding H, de Ferranti S Am J Prev Med. 2018; 54(4):e67-e77.

PMID: 29433955 PMC: 5893222. DOI: 10.1016/j.amepre.2018.01.022.

References
1.
. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

2.
Psaty B, Rivara F . Universal screening and drug treatment of dyslipidemia in children and adolescents. JAMA. 2011; 307(3):257-8. DOI: 10.1001/jama.2011.1916. View

3.
Mahoney L, Burns T, Stanford W, Thompson B, Witt J, Rost C . Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol. 1996; 27(2):277-84. DOI: 10.1016/0735-1097(95)00461-0. View

4.
. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011; 128 Suppl 5:S213-56. PMC: 4536582. DOI: 10.1542/peds.2009-2107C. View

5.
McCrindle B, Kwiterovich P, McBride P, Daniels S, Kavey R . Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics. 2012; 130(2):353-6. DOI: 10.1542/peds.2012-1137. View